Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
update
/
details

4baseCare Secures $6M in Series A Funding Led by Yali Capital

NextEdge Admin

12 Aug 2024

2 min 17 sec

Bengaluru-based startup 4baseCare, an Illumina Accelerator company specializing in precision oncology through advanced genomics and digital health technology, has secured $6 million in Series A funding. The round was led by Yali Capital, along with other investors. This investment will be used to enhance 4baseCare’s product offerings, scale operations, and expand its presence across India, as well as other Asian and Middle Eastern countries.

Mathew Cyriac, Founding General Partner at Yali Capital, highlighted the significant potential within the cancer genomics sector, stating that 4baseCare’s ability to incorporate data from underrepresented populations will lead to more accurate treatment recommendations. He emphasized the opportunity to build impactful businesses while improving millions of lives.

Hitesh Goswami, CEO and Co-Founder of 4baseCare, expressed that the new funding will further the company’s mission of making personalized cancer care accessible to millions. The company has already made a significant impact, with its genomic tests benefiting over 10,000 cancer patients across Southeast Asia.

The company’s growth is bolstered by a strong advisory board, including Francis deSouza, a seasoned Silicon Valley tech veteran and former CEO of Illumina, who brings over 30 years of expertise in genomics and healthcare. In the coming months, 4baseCare plans to establish genomics laboratories in the Philippines, Nepal, and Dubai. The focus will also be on developing genomics and digital health solutions, leveraging advanced data analytics to improve clinical insights and treatment recommendations.